FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/01/030216 [Registered on: 04/01/2021] Trial Registered Prospectively
Last Modified On: 30/05/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   Clinical evaluation of the effect on oral administration of Siddha classical drug VILVA ENNAI for the treatment of BRONCHIOLITIS. 
Scientific Title of Study   Clinical evaluation of the effect on oral administration of VILVA ENNAI for the treatment of VALI KANAM. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr K Ragavi Sayi Saranya 
Designation  PG SCHOLAR 
Affiliation  Government Siddha Medical College and Hospital, Palayamkottai 
Address  Department of Kuzhanthai Maruthuvam, Government Siddha Medical College and Hospital, Palayamkottai.

Tirunelveli
TAMIL NADU
627002
India 
Phone  8072252679  
Fax    
Email  drsairagavi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr K Shyamala MDs 
Designation  Lecturer Grade II 
Affiliation  Government Siddha Medical College and Hospital, Palayamkottai 
Address  Department of Kuzhanthai Maruthuvam, Government Siddha Medical College and Hospital, Palayamkottai.

Tirunelveli
TAMIL NADU
627002
India 
Phone  9442277124  
Fax    
Email  shyamsujisathya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr K Shyamala MDs 
Designation  Lecturer Grade II 
Affiliation  Government Siddha Medical College and Hospital, Palayamkottai 
Address  Department of Kuzhanthai Maruthuvam, Government Siddha Medical College and Hospital, Palayamkottai.

Tirunelveli
TAMIL NADU
627002
India 
Phone  9442277124  
Fax    
Email  shyamsujisathya@gmail.com  
 
Source of Monetary or Material Support  
Government Siddha Medical College and Hospital, Palayamkottai, Tirunelveli - 627002 
 
Primary Sponsor  
Name  Dr K Ragavi Sayi Saranya 
Address  II year PG Scholar, Department of Kuzhanthai Maruthuvam, Government Siddha Medical College and Hospital, Palayamkottai. Tirunelveli - 627002. 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr K Ragavi Sayi Saranya  Government siddha medical college and hospital, Palayamkottai  Department of kuzhanthai Maruthuvam, Government Siddha Medical College and Hospital, Palayamkottai.
Tirunelveli
TAMIL NADU 
8072252679

drsairagavi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J219||Acute bronchiolitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not Applicable   Not Applicable  
Intervention  VILVA ENNAI  Should be administered orally once a day at morning before the food for a period of 10 days Dose : 4 ml 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  subjects with any of the following symptoms will be included in the study
1. Fever associated with Respiratory symptoms, Urinary tract symptoms and Gastrointestinal symptoms
2. Loss of appetite
3. Cough
4. Vomitting
5. Wheezing
6. Decreased urine output
7. Thirsty
8. Dryness of mouth
9. Constipation 
 
ExclusionCriteria 
Details  1. Children below 3 years and above 12 years
2. Fever due to malignancy, trauma, psychological factors
3. High grade fever
4. Cough with hemoptysis
5. Fever associated with other complications such as HIV, meningitis, Tuberculosis
6. Cardiac diseases
7. Chronic Renal diseases
8. Severe Dehydration 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Decreases the body temperature, cough, vomitting, constipation and other clinical symptoms.  10 days 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "56"
Final Enrollment numbers achieved (India)="56" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   05/01/2021 
Date of Study Completion (India) 02/04/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
Evaluation of analytical specifications of Siddha herbal formulation VILVA ENNAI for VALI KANAM & Standardization of Siddha drug formulation MANDOORA ADAI KIYAZHAM for the management of VADHA SOOBAI 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
The study is a single arm clinical trial to evaluate the therapeutic efficacy of VILVA ENNAI for the treatment of VALI KANAM. The trial drug will be administered orally at the dose of 4 ml before the food once a day at morning for a period of 10 days in 56 patients. The trial period of 24 months will be carrying out in Government Siddha Medical College and Hospital, Palayamkottai, Tirunelveli, Tamilnadu. 
Close